Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: University at Buffalo Division of Behavioral Medicine
Location: G56 Farber Hall, Buffalo, NY, United States 14214
Lead Doctor: Leonard H. Epstein, Ph.D.
IRB Committee: This study has been reviewed and approved by the University at Buffalo Institutional Review Board

Background

 

About 9.4% of the US population has diabetes. Taking medications on time as prescribed by a doctor can help prevent the progression of hypertension, hyperlipidemia, and other comorbidities. However, adherence to diabetes medications is relatively low. The reason for this is people commonly forget to take medications.

This study seeks to assess the effectiveness of a new approach for improving medication adherence in individuals with pre- and type 2 diabetes. In this study, participants will engage in new ways to improve remembering when to take their medication and will be guided by a research staff member in study sessions.

The study seeks adults aged 18 years old and older who have been diagnosed with either prediabetes, type 2 diabetes. Participants are required to attend 8 study visits at the research site over 15 weeks and may get up to $150 for participating in this study. 

Why Participate? 

 

• You may experience improvements to your diabetic condition. 
• You may experience improvements in your memory, specifically remembering to take your diabetes medication. 
• You will receive proper guidance on your prescribed medication by trained professionals.
• You will be compensated up to $150 for participating in this study.
• You will be helping to advance medical research.

Your Rights

 

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

 

• Adults aged 18 years old and above.
• Must be diagnosed with either prediabetes or type 2 diabetes Must be prescribed with at least 1 oral medication for diabetes (blood glucose regulation), or for related comorbidities e.g., hypertension, hyperlipidemia
• Able to attend 8 study visits at the research site for over approximately 15 weeks.

Please note:

 

Due to the current situation with the COVID-19 pandemic, the study team is currently shifting to remote/virtual sessions to ensure the safety of participants as well as the study staff. Having access to electronic devices such as computers, laptops and the like may impact your ability to participate in this study while COVID-19 is still an ongoing issue.